US2019040001A1PendingUtilityA1

Methods of using substituted tetracycline compounds to modulate rna

62
Assignee: PARATEK PHARM INNCPriority: Oct 24, 2002Filed: Feb 20, 2018Published: Feb 7, 2019
Est. expiryOct 24, 2022(expired)· nominal 20-yr term from priority
Inventors:Stuart B. LevyMichael P. DraperMark L. NelsonGraham Peter Jones
A61P 9/10A61P 9/00A61P 43/00A61P 7/06A61P 3/06A61P 3/10A61P 31/12A61P 35/00A61P 3/04A61P 31/14A61P 25/14A61P 25/28A61P 11/06A61P 19/02A61P 11/00C07C 237/26A61K 31/65
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for modulating RNA with tetracycline compounds is described.

Claims

exact text as granted — not AI-modified
1 . A method for treating a subject for a DTMR, comprising: administering to said subject an effective amount of a tetracycline compound, such that said DTMR is treated. 
     
     
         2 - 56 . (canceled)

Join the waitlist — get patent alerts

Track US2019040001A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.